These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1730510

  • 1. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R, Kristensen J, Sandberg C, Nygren P.
    Int J Cancer; 1992 Jan 21; 50(2):177-85. PubMed ID: 1730510
    [Abstract] [Full Text] [Related]

  • 2. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
    Kristensen J, Jonsson B, Sundström C, Nygren P, Larsson R.
    Med Oncol Tumor Pharmacother; 1992 Jan 21; 9(2):65-74. PubMed ID: 1341718
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
    Nygren P, Kristensen J, Jonsson B, Sundström C, Lönnerholm G, Kreuger A, Larsson R.
    Leukemia; 1992 Nov 21; 6(11):1121-8. PubMed ID: 1434793
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Larsson R, Nygren P, Ekberg M, Slater L.
    Leukemia; 1990 Aug 21; 4(8):567-71. PubMed ID: 2388483
    [Abstract] [Full Text] [Related]

  • 5. Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients.
    Nygren P, Fridborg H, Csoka K, Sundström C, de la Torre M, Kristensen J, Bergh J, Hagberg H, Glimelius B, Rastad J.
    Int J Cancer; 1994 Mar 01; 56(5):715-20. PubMed ID: 8314348
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csoka K, Larsson R, Tholander B, Gerdin E, de la Torre M, Nygren P.
    Gynecol Oncol; 1994 Aug 01; 54(2):163-70. PubMed ID: 7520407
    [Abstract] [Full Text] [Related]

  • 7. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
    Aleskog A, Larsson R, Höglund M, Kristensen J, Nygren P, Lindhagen E.
    Anticancer Drugs; 2005 Mar 01; 16(3):277-83. PubMed ID: 15711179
    [Abstract] [Full Text] [Related]

  • 8. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
    Kristensen J, Nygren P, Liliemark J, Fridborg H, Killander A, Simonsson B, Oberg G, Larsson R.
    Leukemia; 1994 Oct 01; 8(10):1712-7. PubMed ID: 7934168
    [Abstract] [Full Text] [Related]

  • 9. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csóka K, Tholander B, Gerdin E, de la Torre M, Larsson R, Nygren P.
    Int J Cancer; 1997 Sep 17; 72(6):1008-12. PubMed ID: 9378534
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R, Nygren P.
    Int J Cancer; 1990 Jul 15; 46(1):67-72. PubMed ID: 2194983
    [Abstract] [Full Text] [Related]

  • 11. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
    Österroos A, Kashif M, Haglund C, Blom K, Höglund M, Andersson C, Gustafsson MG, Eriksson A, Larsson R.
    Biochem Pharmacol; 2016 Oct 15; 118():40-49. PubMed ID: 27565890
    [Abstract] [Full Text] [Related]

  • 12. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
    Nygren P, Hagberg H, Glimelius B, Sundström C, Kristensen J, Christiansen I, Larsson R.
    Ann Oncol; 1994 Oct 15; 5 Suppl 1():127-31. PubMed ID: 8172809
    [Abstract] [Full Text] [Related]

  • 13. The fluorometric microculture cytotoxicity assay.
    Lindhagen E, Nygren P, Larsson R.
    Nat Protoc; 2008 Oct 15; 3(8):1364-9. PubMed ID: 18714304
    [Abstract] [Full Text] [Related]

  • 14. In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R, Fridborg H, Kristensen J, Sundström C, Nygren P.
    Br J Cancer; 1993 May 15; 67(5):969-74. PubMed ID: 8494730
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
    Larsson R, Fridborg H, Liliemark J, Csoka K, Kristensen J, de la Torre M, Nygren P.
    Eur J Cancer; 1994 May 15; 30A(7):1022-6. PubMed ID: 7946567
    [Abstract] [Full Text] [Related]

  • 16. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
    Fridborg H, Jonsson B, Nygren P, Csoka K, Nilsson K, Oberg G, Kristensen J, Bergh J, Tholander B, Olsen L.
    Br J Cancer; 1994 Jul 15; 70(1):11-7. PubMed ID: 8018519
    [Abstract] [Full Text] [Related]

  • 17. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
    Kravtsov VD, Greer JP, Whitlock JA, Koury MJ.
    Blood; 1998 Aug 01; 92(3):968-80. PubMed ID: 9680366
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of in vitro assessment of cytotoxic drug activity in advanced breast cancer.
    Villman K, Blomqvist C, Larsson R, Nygren P.
    Anticancer Drugs; 2005 Jul 01; 16(6):609-15. PubMed ID: 15930887
    [Abstract] [Full Text] [Related]

  • 19. In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia.
    Lönnerholm G, Frost BM, Larsson R, Liliemark E, Nygren P, Peterson C.
    Adv Exp Med Biol; 1999 Jul 01; 457():429-35. PubMed ID: 10500819
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
    Aleskog A, Larsson R, Höglund M, Sundström C, Kristensen J.
    Eur J Haematol; 1999 May 01; 62(5):293-9. PubMed ID: 10359056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.